Two cases of CPT-11 and CDDP chemotherapy for advanced pancreatic cancer

Kosei Takagi, Kazuyuki Kawamoto, Tadashi Itoh

Research output: Contribution to journalArticlepeer-review


We report two cases of advanced pancreatic cancer treated with CPT-11 and CDDP as third-line chemotherapy. CPT-11 was administered as an intravenous injection at a dose of 60 mg/m2, and CDDP was administered at a dose of 30 mg/m2 biweekly. The patients showed no adverse events greater than grade 2 toxicity, and these adverse events were tolerated. The patients showed partial response and stable disease. These results suggested that this treatment schedule was safe and effective for progressive pancreatic cancer.

Original languageEnglish
Pages (from-to)847-849
Number of pages3
JournalJapanese Journal of Cancer and Chemotherapy
Issue number5
Publication statusPublished - May 2012
Externally publishedYes


  • CPT-11 and CDDP chemotherapy
  • Pancreatic cancer

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Two cases of CPT-11 and CDDP chemotherapy for advanced pancreatic cancer'. Together they form a unique fingerprint.

Cite this